Faculty Disclosure
All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.
Sara Schaefer: Course Director
Nothing to Disclose
Veronica Santini: Reviewer
Grant: Insightec, Biogen, Roche / Genentech
Carla Palleis: Author
Nothing to disclose
Matthias Brendel: Author
Speaker honoraria from GE Healthcare and LMI and is an adviser of LMI
Anika Finze: Author
Nothing to disclose
Endy Weidinger: Author
Nothing to disclose
Kai Bötzel: Author
Nothing to disclose
Adrian Danek: Author
Nothing to disclose
Leonie Beyer: Author
Nothing to disclose
Alexander Nitschmann: Author
Nothing to disclose
Maike Kern: Author
Nothing to disclose
Gloria Biechele: Author
Nothing to disclose
Boris-Stephan Rauchmann: Author
Nothing to disclose
Jan Häckert: Author
Nothing to disclose
Matthias Höllerhage: Author
Nothing to disclose
Andrew W. Stephens: Author
Employee: LMI
Alexander Drzezga: Author
Nothing to disclose
Thilo van Eimeren: Author
Nothing to disclose
Victor L. Villemagne: Author
Nothing to disclose
Andreas Schildan: Author
Nothing to disclose
Henryk Barthel: Author
Nothing to disclose
Marianne Patt: Author
Nothing to disclose
Osama Sabri: Author
Research funding: LMI
German Imaging Initiative for Tauopathies (GII4T): Author
Nothing to disclose
Peter Bartenstein: Author
Nothing to disclose
Robert Perneczky: Author
Advisory board: Biogen; Consultant: Eli Lilly; Grant Recipient: Janssen Pharmaceutica and Boehringer Ingelheim; Speaker honoraria: Janssen-Cilag, Pfizer, and Biogen
Christian Haass: Author
Chief Scientific Adviser of ISAR Biosciences; Collaboration: DENALI Therapeutics
Johannes Levin: Author
Speaker fee: Bayer Vital; Consulting fee: Axon Neuroscience; Author fee: Thieme medical publishers and W. Kohlhammer GmbH medical publishers; Nonfinancial support: AbbVie, Part-time CMO from MODAG GmbH, all outside the submitted work
Günter U. Höglinger: Author
Research collaboration: Prothena; Consultant: AbbVie, AlzProtect, Asceneuron, Biogen, Biohaven, Lundbeck, Novartis, Roche, Sanofi, UCB; Honoraria: AbbVie, Bial, Biogen, Bristol Myers Squibb, Roche, Teva, UCB, and Zambon; Patent: PERK Activation for the Treatment of Neurodegenerative Diseases (PCT/EP2015/068734)